DK2123271T3 - Lægemiddel til behandling af influenza - Google Patents
Lægemiddel til behandling af influenzaInfo
- Publication number
- DK2123271T3 DK2123271T3 DK08721158.7T DK08721158T DK2123271T3 DK 2123271 T3 DK2123271 T3 DK 2123271T3 DK 08721158 T DK08721158 T DK 08721158T DK 2123271 T3 DK2123271 T3 DK 2123271T3
- Authority
- DK
- Denmark
- Prior art keywords
- influenza
- medication
- treatment
- prophylactic
- therapeutic
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 206010064097 avian influenza Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007056872 | 2007-03-07 | ||
| PCT/JP2008/053738 WO2008108323A1 (ja) | 2007-03-07 | 2008-03-03 | インフルエンザ治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2123271T3 true DK2123271T3 (da) | 2012-01-23 |
Family
ID=39738201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08721158.7T DK2123271T3 (da) | 2007-03-07 | 2008-03-03 | Lægemiddel til behandling af influenza |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20100204314A1 (da) |
| EP (1) | EP2123271B1 (da) |
| JP (2) | JP5286251B2 (da) |
| KR (1) | KR101473028B1 (da) |
| CN (1) | CN101715343B (da) |
| AT (1) | ATE526960T1 (da) |
| CA (1) | CA2680415A1 (da) |
| CY (1) | CY1112201T1 (da) |
| DK (1) | DK2123271T3 (da) |
| ES (1) | ES2372996T3 (da) |
| HR (1) | HRP20110861T1 (da) |
| PL (1) | PL2123271T3 (da) |
| PT (1) | PT2123271E (da) |
| SI (1) | SI2123271T1 (da) |
| TW (1) | TWI424841B (da) |
| WO (1) | WO2008108323A1 (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| JP5986745B2 (ja) | 2008-07-15 | 2016-09-06 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法 |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| CN103068378B (zh) * | 2010-05-10 | 2016-07-06 | 中央研究院 | 具有抗流感活性的扎那米韦膦酸酯同类物及其制备方法 |
| CA2859296C (en) * | 2011-12-16 | 2016-10-11 | Daiichi Sankyo Company, Limited | Method for manufacturing neuraminic acid derivatives |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| WO2014031498A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| EP3013365B1 (en) | 2013-06-26 | 2019-06-05 | Academia Sinica | Rm2 antigens and use thereof |
| WO2014210564A1 (en) | 2013-06-27 | 2014-12-31 | Academia Sinica | Glycan conjugates and use thereof |
| US9782476B2 (en) | 2013-09-06 | 2017-10-10 | Academia Sinica | Human iNKT cell activation using glycolipids with altered glycosyl groups |
| CA2937123A1 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| WO2015148915A1 (en) | 2014-03-27 | 2015-10-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| KR102512592B1 (ko) | 2014-05-27 | 2023-03-21 | 아카데미아 시니카 | 항-ｈｅｒ2 글리코항체 및 이의 용도 |
| CA2950423A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| KR20170003720A (ko) | 2014-05-27 | 2017-01-09 | 아카데미아 시니카 | 항-ｃｄ20 글리코항체 및 이의 용도 |
| CN106714829A (zh) | 2014-05-28 | 2017-05-24 | 中央研究院 | 抗TNF‑α醣抗体及其用途 |
| CA2960712A1 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | Human inkt cell activation using glycolipids |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| AU2015378564A1 (en) | 2015-01-24 | 2017-07-13 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| WO2017156192A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
| EP3500594A4 (en) | 2016-08-22 | 2020-03-11 | Cho Pharma Inc. | ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE |
| WO2019073298A1 (en) * | 2017-10-11 | 2019-04-18 | Lifescience As | N-acetylneuraminic acid compositions and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3209946B2 (ja) * | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| ATE211468T1 (de) * | 1996-07-22 | 2002-01-15 | Sankyo Co | Neuraminsäuredervate, ihre herstellung und medizinische verwendung |
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6340702B1 (en) * | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP4151800B2 (ja) | 1996-08-13 | 2008-09-17 | 第一三共株式会社 | ノイラミン酸化合物 |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| JP3920041B2 (ja) | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| DE602006003600D1 (de) | 2005-08-22 | 2008-12-24 | Delphi Tech Inc | Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad |
-
2008
- 2008-03-03 DK DK08721158.7T patent/DK2123271T3/da active
- 2008-03-03 PL PL08721158T patent/PL2123271T3/pl unknown
- 2008-03-03 ES ES08721158T patent/ES2372996T3/es active Active
- 2008-03-03 KR KR1020097018422A patent/KR101473028B1/ko active Active
- 2008-03-03 EP EP08721158A patent/EP2123271B1/en not_active Not-in-force
- 2008-03-03 US US12/449,909 patent/US20100204314A1/en not_active Abandoned
- 2008-03-03 HR HR20110861T patent/HRP20110861T1/hr unknown
- 2008-03-03 PT PT08721158T patent/PT2123271E/pt unknown
- 2008-03-03 CN CN2008800149108A patent/CN101715343B/zh active Active
- 2008-03-03 AT AT08721158T patent/ATE526960T1/de active
- 2008-03-03 CA CA002680415A patent/CA2680415A1/en not_active Abandoned
- 2008-03-03 JP JP2009502568A patent/JP5286251B2/ja active Active
- 2008-03-03 WO PCT/JP2008/053738 patent/WO2008108323A1/ja not_active Ceased
- 2008-03-03 SI SI200830440T patent/SI2123271T1/sl unknown
- 2008-03-07 TW TW097107984A patent/TWI424841B/zh active
-
2011
- 2011-12-30 CY CY20111101293T patent/CY1112201T1/el unknown
-
2013
- 2013-04-22 JP JP2013089202A patent/JP6012076B2/ja active Active
- 2013-08-27 US US14/010,784 patent/US20140018418A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL2123271T3 (pl) | 2012-03-30 |
| CY1112201T1 (el) | 2015-12-09 |
| EP2123271B1 (en) | 2011-10-05 |
| PT2123271E (pt) | 2011-12-20 |
| KR101473028B1 (ko) | 2014-12-15 |
| JPWO2008108323A1 (ja) | 2010-06-17 |
| EP2123271A1 (en) | 2009-11-25 |
| HK1137142A1 (en) | 2010-07-23 |
| CA2680415A1 (en) | 2008-09-12 |
| US20140018418A1 (en) | 2014-01-16 |
| EP2123271A4 (en) | 2010-03-17 |
| HRP20110861T1 (hr) | 2011-12-31 |
| CN101715343B (zh) | 2012-09-26 |
| JP6012076B2 (ja) | 2016-10-25 |
| TWI424841B (zh) | 2014-02-01 |
| JP2013139483A (ja) | 2013-07-18 |
| ATE526960T1 (de) | 2011-10-15 |
| KR20090129414A (ko) | 2009-12-16 |
| US20100204314A1 (en) | 2010-08-12 |
| WO2008108323A1 (ja) | 2008-09-12 |
| JP5286251B2 (ja) | 2013-09-11 |
| CN101715343A (zh) | 2010-05-26 |
| ES2372996T3 (es) | 2012-01-30 |
| SI2123271T1 (sl) | 2012-05-31 |
| TW200848018A (en) | 2008-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2123271T3 (da) | Lægemiddel til behandling af influenza | |
| PT2192109E (pt) | Derivado de -aminoácido bicíclico | |
| BRPI1009637A2 (pt) | composto, composição e uso de um composto | |
| BR112012014858A2 (pt) | agente antiplaqueta | |
| HRP20120323T1 (en) | Diarylhydantoin compounds | |
| UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
| DK2080516T3 (da) | Anvendelse af isothiocyanatderivater som anti-myelom-midler | |
| SG171617A1 (en) | Therapeutic compounds | |
| UA115666C2 (uk) | Заміщена оксимом амідна сполука і засіб для боротьби зі шкідниками | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| DK1694318T3 (da) | (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum | |
| DK1987025T3 (da) | Benzoxazinon og benzoxazepinonoxazolidinoner som antibakterielle midler | |
| HK1202288A1 (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives | |
| MA32192B1 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
| MX2009012125A (es) | Compuestos terapeuticos. | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| ATE503746T1 (de) | Neue imidazolidinderivate | |
| MY160882A (en) | Biocidal composition and method | |
| BR112012027387A2 (pt) | composição para controle de doenças de plantas e uso da mesma | |
| WO2009051223A1 (ja) | 白内障処置のための医薬組成物 | |
| EP2602254A4 (en) | HETEROCYCLIC CONNECTION | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| NO20064344L (no) | Caspaseinhibitorer og anvendelser derav | |
| BR0208812A (pt) | Derivados fenil heterociclil éter como inibidores de recaptação de serotonina | |
| BRPI0811220A2 (pt) | Compostos terapêuticos |